Bacteria all around us produce an endless variety of bioactive small molecules. Yale Chemistry Professor, Jason Crawford, has harnessed rapid sequencing technology to mine the bacterial genome in search of novel natural products for drug development.
A Yale-led study has found that SIV, which causes AIDS in various non-human primates, leads to disruption of gut microbiome that may give rise to many of the deadly infections that compromise host health.
Yale researchers’ recent study published in PLOS Pathogens will help us treat Dengue fever, a growing international public health issue.
Idiopathic Pulmonary Fibrosis is one of mankind’s deadliest and most mysterious lung diseases. A new study led by Yale School of Medicine, however, is beginning to shed light on IPF’s previously uncharted territory.
Novel technique uses computers, rather than scalpels, to identify specific genes related to kidney disease.
A clinical trial led by Yale professor Kevan Herold may lead to an effective new treatment for type 1 diabetes.
Why is the TB/HIV dual epidemic so pervasive in sub-Saharan Africa? Dr. Richard Bucala’s research at the Yale School of Medicine suggests genetics holds the answer.
In a collaborative study, researchers from several Yale departments have developed small synthetic molecules that limit damage to the heart from ischemia, which could potentially be developed into drugs to be used in a surgical or therapeutic setting.
During fieldwork, Dr. Isaac Bogoch assembled a microscope from an iPhone, an $8 ball lens, and some tape, to detect hookworms in 200 Tanzanian children. The invention gives hope for increased detection of the disease in rural Africa and around the world.
An ingenious, easy-to-use diagnostic device developed by Vanderbilt professor Dr. Rick Haselton could be a game-changer in the fight against malaria.